Observational Study of the effect of SGLT2 inhibitor on Glycemic Control Indices

Observational Study of the effect of SGLT2 inhibitor on Glycemic Control Indices - Observational Study of the effect of SGLT2 inhibitor on Glycemic Control Indices

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000050228

Enrollment

4250

Registered

2023-04-01

Start date

2023-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes mellitus

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who visited Nagoya university hospital or the joint research institute between April 17,2014 and December 31,2022 Those with the data both HbA1c and glycated albumin measured simultaneously Those with the data both HbA1c and glucose management indicator measured simultaneously

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Comparison of GA/HbA1c ratio between patients taking SGLT2 inhibitor and those not	—

Secondary

Measure	Time frame
Comparison of glycemic control indices between patients taking SGLT2 inhibitor and those not Exploratory analysis of factors contributing to glycemic control indices	—

Countries

Japan

Contacts

Public ContactTakeshi Onoue

Nagoya University Graduate School of Medicine Department of Endocrinology and Diabetes

t-onoue@med.nagoya-u.ac.jp052-744-2142

Outcome results